Influence of the interimplant distance on crestal bone resorption and bone density: a histomorphometric study in dogs.

J Periodontol

Department of Restorative Dentistry, School of Dentistry of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.

Published: April 2006

Background: The position of gingival soft tissues depends on the position and health of the underlying alveolar bone. The aim of this study was to evaluate the influence of different interimplant distances on crestal bone resorption after prosthetic restoration with a 5-mm distance between the contact point and the bone crest.

Methods: The mandibular bilateral premolars of six dogs were extracted and, after 12 weeks, each dog received eight implants, totaling 48 implants in the experiment. Two pairs, one in each hemiarch, were separated by 2 mm (group 1) and two by 3 mm (group 2). After 12 weeks, the implants received temporary acrylic prostheses. After 4 more weeks, metallic crowns substituted the temporary prostheses. After 4 more weeks, the animals were sacrificed, and their hemimandibles were removed, dissected, and processed.

Results: For groups 1 and 2, respectively, the mean of interimplant bone resorption (IIBR) analyzed histologically was 2.03 and 1.98 mm (P >or=0.05), and the mean of the distal extension bone resorption was 2.04 and 1.92 mm for groups 1 and 2, respectively (P >or=0.05). The crestal bone resorption between the implants was 0.13 mm (P >or=0.05) for both groups. The mean of IIBD for groups 1 and 2 was 79% and 80%, respectively. When the IIBD was compared to the distal extension bone density for group 1 (79% and 64%) and group 2 (80% and 62%), statistically significant differences were obtained for both groups (P
Conclusions: The distances of 2 and 3 mm between implants do not result in statistically significant differences in crestal bone resorption around implant surfaces in dogs. The bone density is enhanced when loading is present at the interimplant area.

Download full-text PDF

Source
http://dx.doi.org/10.1902/jop.2006.050172DOI Listing

Publication Analysis

Top Keywords

bone resorption
20
crestal bone
12
bone
9
influence interimplant
8
bone density
8
prostheses weeks
8
distal extension
8
extension bone
8
resorption
5
groups
5

Similar Publications

Unlabelled: Guided bone regeneration (GBR) is an alternative treatment for craniofacial bone defects reconstruction through membrane barrier adaptation, such as demineralized dentin material membrane (DDMM). DDMM is used as a substitute for GBR material, which aligns with Green Economy principles, it has a good biological osteoinductive and osteoconductive effects, and its structure resembles bones. The balance of bone remodeling when experiencing craniofacial defects will be altered and allow changes to resorption activity, so the mechanisms of osteoclastogenesis and bone resorption are vital.

View Article and Find Full Text PDF

Targeting TRPC channels for control of arthritis-induced bone erosion.

Sci Adv

January 2025

Fels Cancer Institute for Personalized Medicine, Department of Cancer & Cellular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA.

Arthritis leads to bone erosion due to an imbalance between osteoclast and osteoblast function. Our prior investigations revealed that the Ca-selective ion channel, Orai1, is critical for osteoclast maturation. Here, we show that the small-molecule ELP-004 preferentially inhibits transient receptor potential canonical (TRPC) channels.

View Article and Find Full Text PDF

Effect of romosozumab on bone mineral density and trabecular bone score in premenopausal women with low bone mass.

Osteoporos Int

January 2025

Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine, 50-1 Yonsei-Ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.

Unlabelled: We investigated the efficacy of romosozumab in premenopausal women with low bone mass. Romosozumab substantially increased bone mineral density and trabecular bone score in these women, aligning with its proven therapeutic benefits for postmenopausal osteoporosis.

Purpose: Romosozumab, an anti-sclerostin antibody, is a promising anabolic agent that increases bone formation and decreases bone resorption.

View Article and Find Full Text PDF

Bone turnover assessment and monitoring are essential for chronic kidney disease (CKD)-associated bone care. Patients with CKD suffer from significantly elevated fracture risk due to abnormally high or low bone turnover, which requires diametrically opposite treatments informed by patient-specific bone turnover data. However, a reliable, accessible, non-invasive bone turnover assessment and monitoring tool remains an unmet clinical need.

View Article and Find Full Text PDF

[Metabolic bone diseases : what's new in 2024].

Rev Med Suisse

January 2025

Centre interdisciplinaire des maladies osseuses, Département de l'appareil locomoteur, Centre hospitalier universitaire vaudois, 1011 Lausanne.

The epidemiology of femoral fractures is changing, with more femoral shaft fractures linked to high-risk physical exercise by an older population. Vitamin D given during pregnancy for the mother's health could benefit the child. Zoledronic acid is the most effective bisphosphonate.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!